The China Mail - Warmer noses are better at fighting colds: study

USD -
AED 3.672502
AFN 64.503014
ALL 81.192085
AMD 377.80312
ANG 1.79008
AOA 916.999719
ARS 1404.559202
AUD 1.40388
AWG 1.8
AZN 1.696955
BAM 1.646054
BBD 2.018668
BDT 122.599785
BGN 1.67937
BHD 0.377032
BIF 2970.534519
BMD 1
BND 1.265307
BOB 6.925689
BRL 5.200198
BSD 1.00223
BTN 90.830132
BWP 13.131062
BYN 2.874696
BYR 19600
BZD 2.015696
CAD 1.358022
CDF 2224.999745
CHF 0.7713
CLF 0.021644
CLP 854.640367
CNY 6.91325
CNH 6.90005
COP 3673.06
CRC 495.722395
CUC 1
CUP 26.5
CVE 92.801205
CZK 20.44695
DJF 178.476144
DKK 6.296865
DOP 62.819558
DZD 129.636078
EGP 46.866398
ERN 15
ETB 155.585967
EUR 0.842797
FJD 2.18685
FKP 0.731875
GBP 0.73421
GEL 2.69023
GGP 0.731875
GHS 11.014278
GIP 0.731875
GMD 73.489964
GNF 8797.562638
GTQ 7.686513
GYD 209.681152
HKD 7.816935
HNL 26.485379
HRK 6.351032
HTG 131.354363
HUF 319.825501
IDR 16833
ILS 3.069625
IMP 0.731875
INR 90.5975
IQD 1312.932384
IRR 42125.000158
ISK 122.380302
JEP 0.731875
JMD 156.812577
JOD 0.709025
JPY 153.0365
KES 129.290011
KGS 87.450025
KHR 4038.176677
KMF 414.999836
KPW 899.999067
KRW 1439.114991
KWD 0.30698
KYD 0.835227
KZT 494.5042
LAK 21523.403145
LBP 89531.808073
LKR 310.020367
LRD 186.915337
LSL 15.915822
LTL 2.95274
LVL 0.60489
LYD 6.309703
MAD 9.134015
MDL 16.932406
MGA 4437.056831
MKD 51.940666
MMK 2099.913606
MNT 3568.190929
MOP 8.069569
MRU 39.799019
MUR 45.90319
MVR 15.45984
MWK 1737.88994
MXN 17.191602
MYR 3.907058
MZN 63.889738
NAD 15.916023
NGN 1354.009762
NIO 36.880244
NOK 9.476925
NPR 145.330825
NZD 1.65372
OMR 0.384512
PAB 1.002209
PEN 3.365049
PGK 4.301573
PHP 58.121504
PKR 281.28012
PLN 3.556625
PYG 6618.637221
QAR 3.654061
RON 4.291103
RSD 98.882844
RUB 77.100343
RWF 1463.258625
SAR 3.750263
SBD 8.048395
SCR 13.730079
SDG 601.4974
SEK 8.892315
SGD 1.262305
SHP 0.750259
SLE 24.249679
SLL 20969.499267
SOS 572.813655
SRD 37.777002
STD 20697.981008
STN 20.619945
SVC 8.769715
SYP 11059.574895
SZL 15.90934
THB 31.074499
TJS 9.410992
TMT 3.5
TND 2.881959
TOP 2.40776
TRY 43.643964
TTD 6.79695
TWD 31.401096
TZS 2590.153987
UAH 43.122365
UGX 3543.21928
UYU 38.428359
UZS 12348.557217
VES 388.253525
VND 25965
VUV 119.366255
WST 2.707053
XAF 552.07568
XAG 0.011903
XAU 0.000197
XCD 2.70255
XCG 1.806292
XDR 0.686599
XOF 552.073357
XPF 100.374109
YER 238.401494
ZAR 15.879725
ZMK 9001.201678
ZMW 19.067978
ZWL 321.999592
  • CMSD

    -0.0100

    24.07

    -0.04%

  • BCC

    -0.3200

    89.41

    -0.36%

  • GSK

    -0.3300

    58.49

    -0.56%

  • BCE

    -0.1800

    25.65

    -0.7%

  • AZN

    11.3600

    204.76

    +5.55%

  • RIO

    2.2800

    99.52

    +2.29%

  • JRI

    0.3500

    13.13

    +2.67%

  • RBGPF

    0.1000

    82.5

    +0.12%

  • BTI

    0.1400

    60.33

    +0.23%

  • CMSC

    0.0084

    23.7

    +0.04%

  • NGG

    1.8800

    90.64

    +2.07%

  • BP

    1.5800

    38.55

    +4.1%

  • RYCEF

    -0.4800

    16.93

    -2.84%

  • VOD

    0.4300

    15.68

    +2.74%

  • RELX

    -1.5600

    27.73

    -5.63%

Warmer noses are better at fighting colds: study
Warmer noses are better at fighting colds: study / Photo: © AFP

Warmer noses are better at fighting colds: study

Chilly weather and common respiratory infections often go hand in hand.

Text size:

Reasons for this include people gather inside more in winter, and viruses survive better in low-humidity indoor air. But there has been less certainty about whether lower temperatures actually impair human immunity and, if so, how.

Now, a new study published Tuesday in The Journal of Allergy and Clinical Immunology details a previously unknown way that the immune system attacks viral intruders inside the nose -- and finds it works better when it's warm.

These discoveries could pave the way for an eventual treatment against the common cold and other viruses, Mansoor Amiji, a pharmaceutical sciences professor at Northeastern University, who co-led the research, told AFP.

The starting point was previous research by Amiji and colleagues in 2018, which found that nasal cells released "extracellular vesicles" (EVs) —- a spray of tiny sacs that swarmed and destroyed bacteria upon inhalation.

"The best analogy that we have is a hornet's nest," said Amiji. Like hornets defending a nest from attack, EVs swarm, bind to, and kill invaders.

For the new research, the team set out to answer two questions: are EVs also secreted in the nose in the presence of viral infections? And, if they are, is the strength of their response linked to temperature?

To answer the first question, they used a test substance which mimics a viral infection to stimulate nasal mucosa -- a thin tissue that lines the nose -- that was taken from volunteers who had surgery to remove polyps.

They found it did in fact produce EVs that target viruses.

In order to tackle the second question, they divided the nasal cell samples into two groups and cultured them in a lab, subjecting one set of samples to 37 degrees Celsius, and the other to 32C.

These temperatures were chosen based on a separate test that found the temperature inside the nose falls by about 5C when outside air drops from 23C to 4C.

Under regular body heat conditions, the EVs were successfully able to fight off viruses, by presenting them with "decoy" targets that they latch on to instead of the receptors they would otherwise target on cells.

But under the reduced temperatures, fewer EVs were produced, and those that were made packed less punch against the invaders tested: two rhinoviruses and a non-Covid coronavirus, which are typically found in winter cold season.

"There's never been a convincing reason why you have this very clear increase in viral infectivity in the cold months," said co-author Benjamin Bleier, a surgeon at Harvard Medical School and Massachusetts Eye and Ear, in a statement.

"This is the first quantitative and biologically plausible explanation that has been developed."

One of the most exciting aspects of the work is the potential to rev up the body's natural production of virus-targeting EVs in order to fight or even fend off the cold -- or even the flu and Covid, said Amiji.

"That's an area of great interest for us and we certainly continue to pursue that," he said.

D.Wang--ThChM